An overview of regular dialysis treatment in Japan (as of 31 December 2007).
about
Therapeutic management of diabetic kidney disease.Exploring the mechanisms of renoprotection against progressive glomerulosclerosis.Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach.Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in Hemodialysis Patients: A Longitudinal Study.Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patientsClinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan.Successful treatment of non-Hodgkin's lymphoma with rituximab and dose-adjusted CHOP therapy in a patient with concomitant end-stage renal disease requiring haemodialysis.The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry.Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns.The Glomerular Filtration Rate (GFR) at Dialysis Initiation and Mortality in Chronic Kidney Disease (CKD) in East Asian Populations: A Meta-analysis.Effectiveness of oral iron to manage anemia in long-term hemodialysis patients with the use of ultrapure dialysatePathogenesis and therapeutic implications of cardiorenal syndrome.Clinicopathological insights into lupus glomerulonephritis in Japanese and Asians.Role of chronic kidney disease in cardiovascular disease: are we different from others?The impact of CKD identification in large countries: the burden of illness.Prevalence and incidence of chronic kidney disease stage G5 in Japan.Japan Diabetic Nephropathy Cohort Study: study design, methods, and implementation.Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy.An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013).Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b -Infected Patients on Hemodialysis.Multicenter study of pegylated interferon α-2a monotherapy for hepatitis C virus-infected patients on hemodialysis: REACH study.High mortality rate of infectious diseases in dialysis patients: a comparison with the general population in Japan.Overview of regular dialysis treatment in Japan (as of 31 December 2009).Carvedilol ameliorates low-turnover bone disease in non-obese type 2 diabetes.Ideal timing and predialysis nephrology care duration for dialysis initiation: from analysis of Japanese dialysis initiation survey.Current Status of Hepatitis C Virus-Infected Maintenance Hemodialysis Patients in Japan.Use of Japanese Society for Dialysis Therapy dialysis tables to compare the local and national incidence of dialysis.Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan.Chronic kidney disease prevention--a challenge for Asian countries: report of the Third Asian Forum of Chronic Kidney Disease Initiatives.Complete remission of renal cell carcinoma with lung metastases in two hemodialysis patients after low-dose interferon therapy.High Target Hemoglobin With Erythropoiesis-Stimulating Agents Has Advantages in the Renal Function of Non-Dialysis Chronic Kidney Disease PatientsLate Dialysis Start Did Not Affect Long-Term Outcome in Japanese Dialysis Patients: Long-Term Prognosis From Japanese Society of Dialysis Therapy Registry
P2860
Q30362729-451BCFE6-7033-4AD4-9A07-5FEDCC5044DFQ30499205-38ADE1A2-BC46-4DA6-80FA-A392E5933B2BQ34285987-30521BE0-F051-4C1E-AA63-FC4E6B546F4DQ34672695-6BE1B3AD-71EB-437C-8FD1-ADB90454FB67Q34927028-A067A3D3-922F-4A76-8FA2-B80DFC93A5EEQ35030613-8FB711F5-C210-4AA5-8160-F451CE897086Q35574395-56A835F1-7E08-43F6-B47A-F54BFBE38271Q35849765-024ABDDE-F8E1-4EFC-88E9-31EA8FF4F400Q35983513-D1B14C3F-3576-4200-BA90-DA5D18C7E259Q36179781-A3747A12-F666-4268-A14E-B12765B4C8D2Q36244049-671479B5-ACE7-4143-A44C-D00B8860DED2Q37812022-5050423E-B616-49CD-B86F-23E0CC535090Q37857737-D9003B76-F774-4FD3-8CBA-B50CFF830E75Q37861571-C759023B-499D-42E1-A745-9707E018EC82Q38056884-DF44A77A-7896-4115-B5B4-C77263EBCB04Q38211367-FE422FA2-F909-4D34-8251-F9BA08CA6883Q39460039-B583B5E2-2572-4D90-86A7-3536806DFAC3Q39946556-B869CC3D-6A8F-4734-A40F-03702E6181D4Q40106842-6A28C4D6-97CB-41E3-B4F2-46AA68ECB2D7Q40503590-38C3A912-B9CD-4962-BB5A-D3015FE19A4EQ41750716-9181BBAD-768C-421F-8867-FCE8E6F16917Q43171885-96CA001F-03B0-44BA-B54F-6C6254EA3F11Q43610757-11454BE9-1E33-44CA-8739-040D116B163FQ44047436-F17F910B-29A1-4827-8FCD-0C95DE43D2B6Q44122116-730746DD-355E-4EE2-A58A-8EB0D2D6CDF5Q45325657-AD6FBDB8-6C46-4DA1-9187-2B9F7C5DC0FFQ46211690-CF5D1B77-D6F6-4940-9FEF-C70F983BEEB6Q51045833-A78D05D4-B334-4EE3-853B-E3180D6504C2Q51409315-078DF23F-820F-4D16-8A07-5584221C0B20Q53157291-33312CCA-3F59-4BE8-B1D8-ED376E8EDC4BQ57623230-22009771-DDE7-4D78-A534-09AAEA3A1FC8Q57623236-D0D94C07-A5B8-4806-914C-EB7B148509B2
P2860
An overview of regular dialysis treatment in Japan (as of 31 December 2007).
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
An overview of regular dialysis treatment in Japan (as of 31 December 2007).
@en
type
label
An overview of regular dialysis treatment in Japan (as of 31 December 2007).
@en
prefLabel
An overview of regular dialysis treatment in Japan (as of 31 December 2007).
@en
P2093
P1476
An overview of regular dialysis treatment in Japan (as of 31 December 2007)
@en
P2093
Atsushi Wada
Hidetomo Nakamoto
Hiroshi Nishi
Ikuto Masakane
Kazuyuki Suzuki
Kenji Tsuchida
Kenji Wakai
Kunihiro Yamagata
Kunitoshi Iseki
Masatomo Taniguchi
P304
P356
10.1111/J.1744-9987.2009.00789.X
P577
2009-12-01T00:00:00Z